Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Doxorubicin × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 43 Liver Neoplasms 19 Stomach Neoplasms 11 Neoplasm Metastasis 8 Colorectal Neoplasms 8 Pancreatic Neoplasms 7 Neoplasms 6 Breast Neoplasms 6 Sarcoma 5 Ovarian Neoplasms 5 Hepatoblastoma 5 Colonic Neoplasms 5 Prostatic Neoplasms 4 Peritoneal Neoplasms 3 Lymphoma, Non-Hodgkin 3 Appendiceal Neoplasms 3 Uterine Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Acute 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hodgkin Disease 2

Interventions

Gemcitabine 97 Cisplatin 64 Oxaliplatin 40 pembrolizumab 31 Fluorouracil 30 Capecitabine 30 durvalumab 26 lenvatinib 24 Leucovorin 24 Radiofrequency Ablation 11 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Drug Therapy 11 apatinib 10 Radiotherapy 10 Albumin-Bound Paclitaxel 10 pemigatinib 9 Taxes 9 tislelizumab 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01920503 2019-02-27

CHOLANGIO

International Group of Endovascular Oncology

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡